Position in ARGX
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$9,261,030
+$161,112 QoQ
Shares Held
12,682
+17.2% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Thrivent Financial for Lutherans holds $270,833,554 across 48 Biotechnology names. ARGX ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
1,568,627 | $67,278,411 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
627,699 | $35,458,716 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
75,977 | $33,926,767 | |
| 4 | RPRX |
Royalty Pharma plc
|
499,167 | $23,945,040 | |
| 5 | TECH |
BIO-TECHNE Corp
|
302,934 | $15,831,330 | |
| 6 | ARGX |
Argenx SE
This page
|
12,682 | $9,261,030 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
20,470 | $6,772,908 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,440 | $6,521,080 |
All Filings in ARGX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,261,030 | 12,682 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $9,099,918 | 10,821 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $7,982,610 | 10,823 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $290,492 | 527 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $291,789 | 493 | Shares | Sole | 2025-08-26 | |
| 2024-12-31 | $20,334,975 | 33,065 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $20,247,771 | 37,352 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $15,820,311 | 36,788 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $16,603,959 | 42,172 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $23,542,149 | 61,883 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $33,954,917 | 69,066 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $26,579,585 | 68,200 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $28,747,154 | 77,157 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $28,833,887 | 76,113 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $27,077,875 | 76,697 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $29,470,043 | 77,782 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $25,983,119 | 82,405 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $27,195,754 | 77,660 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $19,472,054 | 64,477 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $26,625,425 | 88,436 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $24,137,106 | 87,647 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $27,884,142 | 94,815 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $21,824,074 | 83,133 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $6,808,477 | 30,229 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,053,500 | 23,180 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||